Neurologic Complications of Cancer and its Treatment

National Cancer Institute: Surveillance Epidemiology and End Results. Available at http://seer.cancer.gov/csr/1975_2006/browse_csr.php?section=1&page=sect_01_table.01.html. Accessed September 2009.

Clouston PD, DeAngelis LM, Posner JB: The spectrum of neurologic disease in patients with systemic cancer. Ann Neurol 1992, 31:268–273.

Gavrilovic IT, Posner J: Brain metastases: epidemiology and pathophysiology. J Neuroncol 2005, 75:5–14.

Tremont-Lukats IW, Bobustuc G, Lagos GK, et al.: Brain metastases from prostate carcinoma: The M.D. Anderson Cancer experience. Cancer 2003, 15:363–368.

Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:575–587.

Delattre JY, Krol G, Thaler HT, et al.: Distribution of brain metastases. Arch Neurol 1988, 45:741–744.

Borgelt B, Gelber R, Kramer S, et al.: The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6:1–9.

Gaspar L, Scott C, Rotman M, et al.: Recursive partioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745.

• Chang EL, Wefel JS, Hess KR, et al.: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol 2009, 10:1037–1044. In this very well-designed trial, the neurocognitive impairment from WBRT was so significant that the study was terminated prematurely.

Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:579-592.

Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982, 49:759–772.

Kaplan JG, DeSouza TG, Farkash A, et al.: Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990, 9:225–229.

Little JR, Dale AJ, Okazaki H: Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 1974, 30:138–143.

Ersboll J, Schultz HB, Thomsen BL, et al.: Meningeal involvement in non-Hodgkin’s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol 1985, 35:487–496.

Chamberlain MC: Carcinomatous meningitis. Arch Neurol 1997, 54:16–17.

• Chamberlain MC: Neoplastic meningitis. Oncologist 2008, 13:967–977. This article offers a recent comprehensive review on the subject of neoplastic meningitis.

Rhodes CH, Glantz MJ, Glantz L, et al.: A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996, 77:543–548.

Chamberlain MC, Glantz M, Groves MD, Wilson WH: Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol 2009, 36:S35–S45.

Chamberlain MC: Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 1998, 38:135–140.

Glantz MJ, Hall WA, Cole BF, et al.: Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer 1995, 75:2919–2931.

Chamberlain MC, Corey-Bloom J: Leptomeningeal metastases: 111indium-DTPA CSF flow studies. Neurology 1991, 41:1765–1769.

Chamberlain MC, Kormanik P, Jaeckle KA, et al. 111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 1999, 52:216–217.

Glantz MJ, LaFollette S, Jaeckle KA, et al.: Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 1999, 17:3110–3116.

Jaeckle KA, Batchelor T, O’Day SJ, et al.: An open trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol 2002, 57:231–239.

Tubian-Hulin M: Incidence, prevalence and distribution of bone metastases. Bone 1991, 12 (Suppl 1):9–10.

Goetz CG: Direct metastatic disease. In Textbook of Clinical Neurology, edn 2. Philadelphia: WB Saunders; 2003:1042–1051.

Chamberlain MC, Kormanik PA: Epidural spinal cord compression: a single institution’s retrospective experience. Neuro Oncol 1999, 1:120–123.

Jaeckle KA, Young DF, Foley KM: The natural history of lumbosacral plexopathy in cancer. Neurology 1985, 35:8–15.

Jaeckle KA: Nerve plexus metastases. Neurol Clin 1991, 9:857–866.

Brazis PW, Masdeu JC, Biller J: Cervical, brachial and lumbosacral plexuses. In Localization in Clinical Neurology. Edited by Brazis PW, Masdeu JC, Biller J. Philadelphia: Lippincott Williams & Wilkins; 2001:75–90.

Biasotto M: Numb chin syndrome as the presenting symptom in carcinomatous meningitis. Ann Oncol 2008, 19:599–601.

Pourmand R: Lambert-eaton myasthenic syndrome. Front Neurol Neurosci 2009, 26:120–125.

Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008, 7:327–340. This article provides a very detailed comprehensive review on the subject with excellent discussion of pathophysiology.

Dalmau J: Limbic encephalitis and variants related to neuronal cell membrane autoantigens. Rinsho Shinkeigaku 2008, 48:871–874.

Rosenfeld MR, Dalmau J: Paraneoplastic syndromes of the nervous system. In Cancer Neurology in Clinical Practice. Edited by Schiff D, Kesari S, Wen PY. New Jersey: Humana Press; 2008:237–255.

• Rogers LR: Management of stroke in cancer. Curr Oncol Rep2008, 10:72–77. This article provides an excellent recent review in an area of neuro-oncology that is lacking strong data, especially in terms of management recommendations.

Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985, 64:16–35.

Navi BB, Kawaguchi K, Hriljac I, et al.: Multifocal stroke from tumor emboli. Arch Neurol 2009, 66:1174–1175.

Razier JJ, DeAngelis L: Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000, 54:1222–1226.

Giglio P, Gilbert MR: Cerebral radiation necrosis. Neurologist 2003, 9:180–188.

DeAngelis LM, Delattre YP, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39:789–796.

Chi D, Behin A, Delattre J-Y: Neurologic complications of radiation therapy. In Cancer Neurology in Clinical Practice. Edited by Schiff D, Kesari S, Wen PY. New Jersey: Humana Press; 2008:259–286.

Meyers CA, Weitzner MA, Valentine AD, et al.: Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998, 16:2522–2527.

Leung WM, Tsang NM, Chang FT, et al.: Lhermitte’s sign among nasopharyngeal cancer patients after radiotherapy. Head Neck 2005, 27:187–194.

Uchida K, Nakajima H, Takamura T, et al.: Neurological improvement associated with resolution of irradiation-induced myelopathy: serial magnetic resonance imaging and positron emission tomography findings. J Neuroimaging 2009,19:274–276.

Thyagarajan D, Cascino T, Harms G: Magnetic resonance imaging in brachial plexopathy of cancer. Neurology 1995, 45:421–427.

Wittenberg KH, AdkinsMC: MR imaging of nontraumatic brachial plexopathies: frequency and spectrum of findings. Radiographics 2000, 20:1023–1032.

• Bowen BC, Seidenwurm DJ: Plexopathy. AJNR 2008, 29:400–402. This article provides expert consensus guidelines for neuroimaging in plexopathy.

Bowen BC, Verma A, Brandon AH, et al.: Radiation-induced brachial plexopathy: MR and clinical findings. Am J Neuroradiol 1996, 17:1932–1936.

Wouter van Es H, Engelen AM, Witkamp TD, et al.: Radiation-induced brachial plexopathy: MR imaging. Skeletal Radiol 1997, 26:284–288.

Wolf S, Barton D, Kottschade L, et al.: Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 2008, 44:1507–1515.

• Schiff D, Wen PY, van den Bent MJ: Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev Clin Oncol 2009, 6:596–603. This article provides a very recent review of neurotoxicity caused by targeted and newer therapies.

Harati Y, Bosch EP: Disorders of peripheral nerves. In Neurology in Clinical Practice. Edited by Bradley WG, Daroff RB, Fenichel GM, Jankovic J. Philadelphia: Butterworth-Heinemann; 2008:2249–2356.

Siegal D, Keller A, Xu W, et al.: Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 2007, 13:1369–1379.

Chan KW, Mullen CA, Worth LL, et al.: Lorazepam for seizure prophylaxis during high-dose busulfan administration. Bone Marrow Transplant 2002, 29:963–965.

Sioka C, Kyritsis AP: Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 2009, 63:761–767.